Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Deal Watch: Themis Leverages Measles Vector Platform In Collaboration With Merck & Co.

Fri, 08/23/2019 - 2:15pm

In its first big pharma deal, Austrian biotech will develop experimental vaccines for Merck against an undisclosed target. Innovent licenses...

      Related Stories 

Finance Watch: Five More Biopharmas Enter US Queue Even As IPO Returns Dip

Fri, 08/23/2019 - 1:28pm

Public Company Edition: SpringWorks has the biggest IPO ambitions of recent US filers. Also, Deciphera raises $400m after good data...

      Related Stories 

DREAMM-2 Put GSK’s BCMA Drug In Pole Position In Multiple Myeloma

Fri, 08/23/2019 - 7:05am

The DREAMM-2 trial of the antibody-drug conjugate belantamab mafodotin in relapsed/refractory multiple myeloma patients has hit its primary endpoint, giving...

      Related Stories 

Lupin Rationalizes Japan Operations, Sheds Injectables Business

Fri, 08/23/2019 - 2:17am

Lupin sells Japanese injectables business, eight years after it made an acquisition in that segment there. The Indian firm now...

      Related Stories 

Finance Watch: Chinook Debuts With $65m For Precision Kidney Disease Medicines

Thu, 08/22/2019 - 1:21pm

Private Company Edition: The start-up intends to take multiple drug candidates into the clinic by 2021. Also, Graybug Vision raises...

      Related Stories 

AstraZeneca Buys Priority Review Voucher With Two Big Filings On The Horizon

Thu, 08/22/2019 - 12:14pm

AstraZeneca paid $95m to Swedish Orphan Biovitrum for the voucher, which it could use to expedite the FDA review of...

      Related Stories 

NICE Head Sir Andrew Dillon To Stand Down

Thu, 08/22/2019 - 9:23am

Sir Andrew Dillon is leaving his role as CEO of England’s health technology assessment body after 20 years.

      Related Stories 

Novo Nordisk's Ultra-Fast Acting Insulin Cleared For Pediatric Use In EU

Thu, 08/22/2019 - 8:41am

A market opportunity has just opened up for Novo Nordisk’s ultra-fast acting mealtime insulin, Fiasp: its indications have just been...

      Related Stories 

Longer Intervals OK With ViiV's Injectable Anti-HIV Regimen

Thu, 08/22/2019 - 6:38am

Topline results from the Phase III ATLAS-2M study indicate that injections every two months of ViiV/Janssen’s two-drug anti-HIV regimen are...

      Related Stories 

Oncorus Raises $79.5m To Take Its First Oncolytic Virus Into The Clinic

Wed, 08/21/2019 - 1:03pm

The company has two oncolytic virus platforms – a herpes simplex-based intratumoral injection and a synthetic virus-based intravenous technology for...

      Related Stories 

Synlogic Pivots After First Clinical Failure

Wed, 08/21/2019 - 12:35pm

The synthetic biotics company is discontinuing development of SNYB1020, its first clinical-stage product, which failed to lower blood ammonia in...

      Related Stories 

Big Pharma Nibbles As Turkey’s Localization Policy Yields Limited Results

Wed, 08/21/2019 - 7:19am

The Turkish Government’s carrot-and-stick “localization” policy has started to yield results with some multinational pharma companies including GSK and Sanofi...

      Related Stories 

Pages